Stroma Therapeutics Limited
Research and experimental development on biotechnology · Edinburgh
ActiveUnited KingdomIncorporated 2020Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2025-06-30
IXBRL · 96 source facts · 14 selected values
Validation findingsXBRL valid
Accounts to 2025-06-30
IXBRL · 96 source facts · 14 selected values
Validation findings
XBRL valid
- Reporting period
- 2024-07-01 to 2025-06-30
- Extraction status
- complete
- Numeric facts
- 44
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2024-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2603_SC657504_20250630
- Source archive
- Accounts_Monthly_Data-March2026.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Accounts to 2024-06-30
IXBRL · 94 source facts · 14 selected values
Validation cleanXBRL valid
Accounts to 2024-06-30
IXBRL · 94 source facts · 14 selected values
Validation clean
XBRL valid
- Reporting period
- 2023-07-01 to 2024-06-30
- Extraction status
- complete
- Numeric facts
- 42
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- valid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2503_SC657504_20240630
- Source archive
- Accounts_Monthly_Data-March2025.zip
Accounts to 2023-06-30
IXBRL · 93 source facts · 18 selected values
Not assessedlegacy record
Accounts to 2023-06-30
IXBRL · 93 source facts · 18 selected values
Not assessed
legacy record
- Reporting period
- 2022-04-01 to 2023-06-30
- Extraction status
- Legacy / not assessed
- Numeric facts
- 38
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2266_SC657504_20230630
- Source archive
- Accounts_Monthly_Data-June2024.zip
Accounts to 2022-03-31
IXBRL · 98 source facts · 21 selected values
Not assessedlegacy record
Accounts to 2022-03-31
IXBRL · 98 source facts · 21 selected values
Not assessed
legacy record
- Reporting period
- 2021-04-01 to 2022-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 53
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0003_SC657504_20220331
- Source archive
- Accounts_Monthly_Data-December2022.zip
Accounts to 2021-03-31
IXBRL · 83 source facts · 10 selected values
Not assessedlegacy record
Accounts to 2021-03-31
IXBRL · 83 source facts · 10 selected values
Not assessed
legacy record
- Reporting period
- 2020-03-16 to 2021-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 29
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0097_SC657504_20210331
- Source archive
- Accounts_Monthly_Data-December2021.zip
Registered details
SC657504- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2020-03-16
- Jurisdiction
- —
- Registered office
- 52, BLACKET PLACE, EDINBURGH, EH9 1RJ, SCOTLAND
Classification
1 SIC codes72110
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
1 matched grantsStroma Therapy against Covid-19 induced fibrosis (STACIF)LeadInnovate UK · Collaborative R&D · 2021-01-01 – 2022-02-28 · with 2 other participants£134,872awarded
Stroma Therapy against Covid-19 induced fibrosis (STACIF)Lead
Innovate UK · Collaborative R&D · 2021-01-01 – 2022-02-28 · with 2 other participants
£134,872
awarded